Mateo Mejia Saldarriaga

4PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 12, 2025
Bridging the Gap: Refining Myeloma Precursors and Their Risk of Progression Through Genomics.

Mateo Mejia Saldarriaga, Polina Bellman

|May 22, 2024
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma.

Mateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz

|Oct 24, 2023
A Novel Digital Educational Strategy Improves Treatment Adherence and Quality of Life in Patients with Multiple Myeloma.

Juan Guio, Andrés Melo, Mateo Mejía Saldarriaga

|Feb 14, 2023
Angioimmunoblastic T-cell lymphoma presenting with severe plasmacytosis mimicking plasma cell leukemia.

Mateo Mejia Saldarriaga, Mohammad Alhomoud, Gail Roboz

Pageof 1

Frequent Collaborators

2 joint publications

Mark Bustoros

1 joint publications

Mohammad Alhomoud

1 joint publications

Madhu M Ouseph

1 joint publications

Juan Guio